Phase I study of MGI 114 (Irofulven) given as either D1, D8 q3 weeks or D1, D5 q4 weeks schedule (sch) as a 30 minute infusion in advanced solid tumors (AST): preliminary results

✍ Scribed by E. Raymond; J. Alexandre; E. Brain; S. Faivre; M. Ould Kaci; S. Vignot; S. Smith; S. Lagree; K. Vanderbilt; J.L. Misset

• Book ID: 117658118
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 357 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)80748-6